Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
daily for 14 days) potentiates the antitumour activity of CDDP and Cyclophosphamide in nude mice bearing human FaDu and A253 head and neck xenografts
and JAK2/JAK2 combinations with IC50 of 406
Molecular Weight: 484
TCN238 is an orally bioavailable mGlu4 receptor positive allosteric modulator (PAM) with an EC50 of 1 μM
interacting with both the orthosteric site and an allosteric site
ARCC-4 hydrate phen (dihydrochloride monohydrate) daily for 14 days) potentiatesARCC 4 is a low nanomolar androgen receptor degrader able to degrade about 95% of cellular androgen receptors. ARCC 4 inhibits prostate tumor cell proliferation, degrades clinically relevant androgen receptor point mutants and unlike enzalutamide, retains antiproliferative effect in a high androgen environment. Product information Molecular Weight: 1042. 19 Formula: C53H58F3N7O8S2 Chemical Name: (2S,4R) 1 [(2S) 2 (2 {4 [(4' {3 [4 cyano 3
US$ 99.99
US$ 129.99
US$ 1110.00
US$ 392.50
US$ 700.00
US$ 444.98
US$ 126.50
US$ 2045.00
US$ 195.00